NEW DELHI :
SERUM Institute of India (SII) -- the maker of the most used COVID-19 vaccine in the country -- on Wednesday announced a cut in price of the jab it plans to sell to States to Rs 300 per dose from the earlier Rs 400. This follows widespread criticism of its pricing policy as it had sold the initial doses of Covishield to the Central Government at Rs 150 per dose.
SII’s CEO Adar Poonawalla on Twitter said, “As a philanthropic gesture on behalf of @SerumInstIndia, I hereby reduce the price to the States from Rs 400 to Rs 300 per dose; this will save thousands of crores of State funds going forward. This will enable more vaccinations and save countless lives.”